Management of Elevated BUN in Pediatric Patients

Introduction to BUN Management

The management of elevated BUN in pediatric patients with impaired renal function should focus on adequate hydration, dietary protein optimization, and kidney replacement therapy when indicated, with careful attention to age-specific needs 1

For severely dehydrated patients, initial fluid therapy with isotonic saline (0.9% NaCl) at 10-20 ml/kg/h should be administered, with a limit of initial reexpansion to 50 ml/kg over the first 4 hours, and fluid therapy should continue to replace the deficit evenly over 48 hours, according to the American Academy of Pediatrics 1
Fluid management in HD patients with elevated BUN should account for residual kidney function, interdialytic weight gain, and blood pressure control 2
Aggressive hydration (2-3 L/m²/day or 200 mL/kg/day if <10 kg) is recommended for patients with malignancies at high risk for tumor lysis syndrome (TLS) 3
Target urine output should be 80-100 mL/m²/hour (4-6 mL/kg/hour if <10 kg) 3

Ensure at least 50% of dietary protein is of high biological value (animal sources), as recommended by the National Kidney Foundation 4
Reintroduce protein within 48 hours to avoid catabolism, according to the American Society of Nephrology 5
Hemodialysis patients should add 0.1 g/kg/day to compensate for dialytic losses, while peritoneal dialysis patients should add 0.15-0.35 g/kg/day based on age, as suggested by the European Renal Association 4

Consider KRT when conservative measures fail to control BUN levels, with options including peritoneal dialysis (PD), hemodialysis (HD), and continuous kidney replacement therapy (CKRT), as recommended by the International Society of Nephrology 5
Hemodialysis is preferred for rapid reduction of BUN, removing urea more efficiently than PD, according to the American Society of Nephrology 5
Notification of a renal specialist for potential dialysis is recommended for high-risk patients 3

Regular monitoring of BUN and creatinine, electrolytes, acid-base status, urine output, and specific gravity is essential, as recommended by the National Kidney Foundation 6
For hemodialysis patients, proper pre-dialysis BUN sampling and post-dialysis BUN sampling techniques are crucial, according to the American Journal of Kidney Diseases 6
For BUN elevation with hyperammonemia, stop protein intake temporarily, provide intravenous glucose and lipids, and maintain glucose infusion rate, as suggested by the European Society of Paediatric Nephrology 5
Close monitoring with a watch-and-wait approach is necessary for patients with hyperuricemia 3
Maintaining adequate hydration is crucial for these patients 3
Monitoring for hypersensitivity reactions, especially in patients with HLA-B*58:01 genetic variant, is essential, according to the American Society of Clinical Oncology 7

Allopurinol should be administered at 50-100 mg/m² every 8 hours orally (maximum 300 mg/m²/day) or 10 mg/kg/day divided every 8 hours (maximum 800 mg/day) for moderate-risk patients, as per the American Society of Clinical Oncology guidelines 3
For patients unable to take oral medication, IV allopurinol at 200-400 mg/m²/day in 1-3 divided doses (maximum 600 mg/day) is recommended 3
A single dose of rasburicase may be considered in select cases for moderate-risk patients 3
Rasburicase should be administered intravenously over 30 minutes, and blood samples for uric acid monitoring must be placed immediately on ice, according to the American Society of Clinical Oncology guidelines 3
High-risk patients should be administered rasburicase (0.15-0.20 mg/kg/day IV) 3
Doses of azathioprine and 6-mercaptopurine should be reduced by 65-75% when used concurrently with allopurinol, as recommended by the American Society of Clinical Oncology 3
Regular monitoring of complete blood counts, renal function, and liver function tests is necessary for patients receiving allopurinol, as per the American Society of Clinical Oncology guidelines 7

Avoid relying solely on BUN for assessing hydration status, as BUN can be normal in dehydrated children, according to the American Academy of Pediatrics 5
Avoid prolonged protein restriction, as it can lead to catabolism, and reintroduce protein within 48 hours, as recommended by the American Society of Nephrology 5
Consider residual kidney function, even minimal, when prescribing dialysis, as it can significantly impact BUN levels, according to the National Kidney Foundation 2
G6PD deficiency, history of anaphylaxis/hypersensitivity reactions, and history of hemolytic reactions or methemoglobinemia are contraindications for rasburicase administration, as stated by the American Society of Clinical Oncology 3
Alkalinization is no longer recommended due to lack of evidence and potential complications (calcium phosphate precipitation, reduced xanthine solubility), as stated by the American Society of Clinical Oncology and the European Hematology Association 3
Calcium administration is not recommended for mild hypocalcemia due to risk of calcium phosphate precipitation; it should only be used for hyperkalemia-induced cardiac arrhythmias, according to the European Hematology Association 8

The evidence strongly supports that early intervention with appropriate hydration and antihyperuricemic therapy significantly reduces morbidity and mortality in pediatric patients with hyperuricemia, particularly in those at risk for TLS, as recommended by the American Society of Clinical Oncology and the European Hematology Association [3] [8]